[{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Amino Acids Mixture","moa":"Amino acid metabolism","graph1":"Undisclosed","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"Primus Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"U.S.A","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Diosmin","moa":"Aryl hydrocarbon receptor","graph1":"Immunology","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CANADA","productType":"Controlled Substance","year":"2021","type":"Inapplicable","leadProduct":"Cannabidiol","moa":"Cannabinoid CB1 receptor","graph1":"Undisclosed","graph2":"Phase I","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"6","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Cannabis","moa":"Cannabinoid receptor 1; Cannabinoid receptor 2; G-protein coupled receptor 12; Glycine receptor subunit alpha-1; Glycine receptor (alpha-1\/beta); Glycine receptor subunit alpha-3; N-arachidonyl glycine receptor; G-protein coupled receptor 55; 5-hydroxytryptamine receptor 1A; 5-hydroxytryptamine receptor 2A; Neuronal acetylcholine receptor subunit alpha-7; Delta-type opioid receptor; Mu-type opioid receptor; Peroxisome proliferator-activated receptor gamma; Transient receptor potential cation channel subfamily V member 1; Voltage-dependent T-type calcium channel subunit alpha-1G; Voltage-dependent T-type calcium channel subunit alpha-1H; Voltage-dependent T-type calcium channel subunit alpha-1I; Transient receptor potential cation channel subfamily A member 1; Transient receptor potential cation channel subfamily M member 8; Transient receptor potential cation channel subfamily V member 2; Transient receptor potential cation channel subfamily V member 3; Transient receptor potential cat","graph1":"Undisclosed","graph2":"Phase I","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"6","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"VIETNAM","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Collagen","moa":"Collagen hydrolysis","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"LALLEMAND HEALTH SOLUTIONS","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"CANADA","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Probiotic","moa":"Immune","graph1":"Psychiatry\/Psychology","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"Nova Mentis Life Science","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"CANADA","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Psilocybine","moa":"Serotonin 2a (5-HT2a) receptor","graph1":"Genetic Disease","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"Halucenex Life Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"CANADA","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Psilocybine","moa":"Serotonin 2a (5-HT2a) receptor","graph1":"Psychiatry\/Psychology","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Solution","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"CANADA","productType":"Controlled Substance","year":"2023","type":"Inapplicable","leadProduct":"Psilocybine","moa":"Serotonin 2a (5-HT2a) receptor","graph1":"Genetic Disease","graph2":"Phase I","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"KGK Science \/ Undisclosed"},{"orgOrder":0,"company":"KGK Science","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"CANADA","productType":"Controlled Substance","year":"2023","type":"Inapplicable","leadProduct":"Psilocybine","moa":"Serotonin 2a (5-HT2a) receptor","graph1":"Genetic Disease","graph2":"Phase I","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"KGK Science \/ Undisclosed"},{"orgOrder":0,"company":"KGK Science","sponsor":"Aker BioMarine","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"NORWAY","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Lysophosphatidylcholine-Rich Oil Extract","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"Canada Royal Enoch Phytomedicine","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"CANADA","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Redsenol-1 Plus","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Amino Acid","year":"2025","type":"Inapplicable","leadProduct":"L-Theanine","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"InterHealth Nutraceuticals, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"CANADA","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"7-Keto","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ InterHealth Nutraceuticals, Inc.","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ InterHealth Nutraceuticals, Inc."},{"orgOrder":0,"company":"KGK Science","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CANADA","productType":"Vaccine","year":"2022","type":"Inapplicable","leadProduct":"Acacia Catechu","moa":"||Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"KGK Science \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"KGK Science \/ Undisclosed"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Amino Acid","year":"2023","type":"Inapplicable","leadProduct":"Alphawave L-Theanine","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Apple Cider Vinegar","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Bdnf Essentials","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase I","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"6","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"JAPAN","productType":"Microorganism","year":"2020","type":"Inapplicable","leadProduct":"Bifidobacterium Breve","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"BELGIUM","productType":"Protein","year":"2025","type":"Inapplicable","leadProduct":"Collagen Peptide","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Delta 9 Tetrahydrocannabinol","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Softgel Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"U.S.A","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Epicor","moa":"Undisclosed","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Gummies","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"GFA-918","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Graminex Wspe","moa":"Undisclosed","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"Royal DSM","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"NETHERLANDS","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Humiome Post Lb","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Dietary Supplement","year":"2020","type":"Inapplicable","leadProduct":"Jointalive","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2025","type":"Inapplicable","leadProduct":"Kids Plus Multi & Omega","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Gummies","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"Church & Dwight Co","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Probiotic","year":"2020","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum 276","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Enzyme","year":"2025","type":"Inapplicable","leadProduct":"Lipase Thera-Blend","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Moodelite T-4003-1","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I\/ Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"7","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"FRANCE","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Oligopin","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Pollen Extract","moa":"Undisclosed","graph1":"Urology","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CANADA","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Aloe Vera","moa":"||Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"KGK Science \/ Undisclosed"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Qualia Mind","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"U.S.A","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Release Supplement","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Phase III","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"10","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Release Supplement","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Uclear","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ KGK Science"},{"orgOrder":0,"company":"KGK Science","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"NORWAY","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"KGK Science \/ KGK Science"}]

Find Clinical Drug Pipeline Developments & Deals by KGK Science

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Collagen Hydrolysate is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.

                          Product Name : Undisclosed

                          Product Type : Protein

                          Upfront Cash : Inapplicable

                          August 29, 2025

                          Lead Product(s) : Collagen Peptide

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Recipient : Rousselot BVBA

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Apple Cider Vinegar is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          August 03, 2025

                          Lead Product(s) : Apple Cider Vinegar

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Recipient : Bragg Live Food Products

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Lysophosphatidylcholine-Rich Oil Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognitive Dysfunction.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          June 24, 2025

                          Lead Product(s) : Lysophosphatidylcholine-Rich Oil Extract

                          Therapeutic Area : Neurology

                          Highest Development Status : Undisclosed

                          Recipient : Aker BioMarine

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Lipase Thera-Blend is a Enzyme drug candidate, which is currently being evaluated in clinical studies for the treatment of Neurocognitive Disorders.

                          Product Name : Undisclosed

                          Product Type : Enzyme

                          Upfront Cash : Inapplicable

                          June 13, 2025

                          Lead Product(s) : Lipase Thera-Blend

                          Therapeutic Area : Neurology

                          Highest Development Status : Undisclosed

                          Recipient : Enzymedica

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : AlphaWave L-Theanine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition.

                          Product Name : AlphaWave L-Theanine

                          Product Type : Amino Acid

                          Upfront Cash : Inapplicable

                          June 04, 2025

                          Lead Product(s) : L-Theanine

                          Therapeutic Area : Neurology

                          Highest Development Status : Undisclosed

                          Recipient : Ethical Naturals, Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Delta 9 Tetrahydrocannabinol is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Marijuana Abuse.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          May 13, 2025

                          Lead Product(s) : Delta 9 Tetrahydrocannabinol

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Undisclosed

                          Recipient : Sobereye Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Humiome Post Lb is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Gastrointestinal Diseases.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          April 22, 2025

                          Lead Product(s) : Humiome Post Lb

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Recipient : Royal DSM

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Graminex Wspe is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Menopause.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          March 21, 2025

                          Lead Product(s) : Graminex Wspe

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Highest Development Status : Phase II

                          Recipient : Graminex LLC

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Kids Plus Multi & Omega is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition.

                          Product Name : Undisclosed

                          Product Type : Vitamins/Minerals/Inorganic Salts

                          Upfront Cash : Inapplicable

                          February 04, 2025

                          Lead Product(s) : Kids Plus Multi & Omega

                          Therapeutic Area : Neurology

                          Highest Development Status : Undisclosed

                          Recipient : SmartyPants Vitamins Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          The MedTech Conference
                          Not Confirmed
                          The MedTech Conference
                          Not Confirmed

                          Details : Uclear is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Urinary Tract Infections.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          December 05, 2024

                          Lead Product(s) : Uclear

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase II

                          Recipient : KEB Nutraceuticals USA, Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank